-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
More Companies Join Race To Ease US Baby Formula Supply Crunch
More Companies Join Race To Ease US Baby Formula Supply Crunch
Danone SA (OTC:DANOY) has been doubling shipments to the U.S. of Neocate formula for infants allergic to cow's milk, while Enfamil maker Reckitt is also working to boost supplies amid a nationwide shortage, company executives said.
In February, Abbott Laboratories (NYSE:ABT) recalled dozens of Similac, Alimentum, and EleCare formulas, creating one of the most urgent food shortages in recent history for U.S. families.
Reuters reported that Reckitt Benckiser Group (OTC:RBGLY) said it is working "extremely closely" with the FDA to increase supply, including expediting the approval of some products made at a facility in Mexico.
Read Next: Abbott CEO Says 'We're Sorry About The Baby Formula Shortage,' Ensures Significant Investment For Future.
Reckitt, which supplies roughly half the U.S. baby formula market, said it is also working with the U.S. Department of Agriculture to expand the availability of formula under a program that helps low-income families.
"The Abbott recall affected 38 markets – it's not only the U.S.," said Magdalena Broseta, Danone's Vice President General Counsel of Specialized Nutrition.
Also See: Baby Formula From Europe Arrives In US: Enough For 9,000 Babies For A Week.
"Their focus is to unblock any logistical situations that other players could be facing," she added. "It's a bit early to say what that would entail."
Broseta said Danone is producing more formula in its Liverpool plant and not rerouting products from elsewhere.
"We will keep on serving our existing geographies at the level of their respective demand," she said.
Photo by Pexels from Pixabay
Danone SA (OTC:DANOY) has been doubling shipments to the U.S. of Neocate formula for infants allergic to cow's milk, while Enfamil maker Reckitt is also working to boost supplies amid a nationwide shortage, company executives said.
达能公司(场外交易代码:DANOY)一直在将对牛奶过敏的婴儿配方奶粉对美国的发货量增加一倍,而安福喜制造商利洁时该公司高管表示,在全国范围内出现短缺的情况下,该公司还在努力增加供应。
In February, Abbott Laboratories (NYSE:ABT) recalled dozens of Similac, Alimentum, and EleCare formulas, creating one of the most urgent food shortages in recent history for U.S. families.
在2月份,雅培(纽约证券交易所股票代码:ABT)召回数十种Similac、Alimentum和EleCare配方奶粉,造成美国家庭近期历史上最紧迫的食品短缺之一。
Reuters reported that Reckitt Benckiser Group (OTC:RBGLY) said it is working "extremely closely" with the FDA to increase supply, including expediting the approval of some products made at a facility in Mexico.
据路透社报道,利洁时本基瑟集团(场外交易:RBGLY)表示,它正在与FDA“非常密切”地合作,以增加供应,包括加快批准在墨西哥的一家工厂生产的一些产品。
Read Next: Abbott CEO Says 'We're Sorry About The Baby Formula Shortage,' Ensures Significant Investment For Future.
接下来请阅读:雅培首席执行官表示:“我们对婴儿配方奶粉短缺深表歉意”,确保了未来的大量投资.
Reckitt, which supplies roughly half the U.S. baby formula market, said it is also working with the U.S. Department of Agriculture to expand the availability of formula under a program that helps low-income families.
利洁时表示,它还在与美国农业部合作,根据一项帮助低收入家庭的计划,扩大婴儿配方奶粉的供应。利洁时约占美国婴儿配方奶粉市场的一半。
"The Abbott recall affected 38 markets – it's not only the U.S.," said Magdalena Broseta, Danone's Vice President General Counsel of Specialized Nutrition.
“雅培的召回影响了38个市场--不仅仅是美国,”达能负责专业营养的副总裁Magdalena Broseta说。
Also See: Baby Formula From Europe Arrives In US: Enough For 9,000 Babies For A Week.
另请参阅:来自欧洲的婴儿配方奶粉抵达美国:足够9000名婴儿吃一周.
"Their focus is to unblock any logistical situations that other players could be facing," she added. "It's a bit early to say what that would entail."
“他们的重点是打通其他玩家可能面临的任何后勤问题,”她补充道。“现在说这将带来什么还为时过早。”
Broseta said Danone is producing more formula in its Liverpool plant and not rerouting products from elsewhere.
Broseta表示,达能正在其利物浦工厂生产更多配方奶粉,而不是从其他地方转移产品。
"We will keep on serving our existing geographies at the level of their respective demand," she said.
她说:“我们将继续为现有地区提供服务,满足他们各自的需求。”
Photo by Pexels from Pixabay
图片来源:PEXEL从…Pixabay
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧